Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
Safety and Immunogenicity Study of Adenovirus-vectored, Intranasal Pandemic Influenza Vaccine.
This study has been completed.
Study NCT00755703 Information provided by Vaxin Inc.
First Received on September 17, 2008. Last Updated on September 11, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Influenza A Subtype H5N1 Infection
Additional conditions recognized in this trial
More general conditions related to this trial
DNA Virus Infections
Respiratory Tract Diseases
Respiratory Tract Infections
RNA Virus Infections
Interventions listed in this trial
Pandemic Influenza Vaccine
Sponsors listed in this trial
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers